Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
3076
Insight Molecular Diagnostics
IMDX
$150M
| $569K | ﹤0.01% |
5,483
+1,964
| +56% | +$186K |
|
3077
Movado Group
MOV
$849M
| $568K | ﹤0.01% |
19,961
+1,864
| +10% | +$42.1K |
|
3078
Spok Holdings
SPOK
$228M
| $568K | ﹤0.01% |
54,136
+2,632
| +5% | +$30.1K |
|
3079
Biglari Holdings Class B
BH
$1.25B
| $567K | ﹤0.01% |
4,275
+93
| +2% | +$11.7K |
|
|
CLVS
3080
DELISTED
Clovis Oncology, Inc.
CLVS
| $563K | ﹤0.01% |
80,235
+23,694
| +42% | +$159K |
|
3081
PUT
iQIYI
IQ
$1.23B
| $562K | ﹤0.01% |
33,800
-208,600
| -86% | -$4.82M |
|
|
AGEN
3082
Agenus
AGEN
$312M
| $561K | ﹤0.01% |
10,513
+6,686
| +175% | +$483K |
|
3083
RB Global
RBA
$20.4B
| $560K | ﹤0.01% |
9,558
+5,475
| +134% | +$321K |
|
3084
REX American Resources
REX
$1.42B
| $560K | ﹤0.01% |
39,906
-1,650
| -4% | -$25.3K |
|
3085
KVH Industries
KVHI
$181M
| $557K | ﹤0.01% |
43,920
+8,473
| +24% | +$112K |
|
3086
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $556K | ﹤0.01% |
+106,468
| New | +$561K |
|
|
EVF
3087
Eaton Vance Senior Income Trust
EVF
$90.3M
| $556K | ﹤0.01% |
+81,012
| New | +$533K |
|
|
TEF
3088
DELISTED
Telefonica
TEF
| $554K | ﹤0.01% |
+137,603
| New | +$560K |
|
|
CCRN
3089
DELISTED
Cross Country Healthcare
CCRN
| $553K | ﹤0.01% |
44,284
+5,291
| +14% | +$56.1K |
|
|
NPTN
3090
DELISTED
NEOPHOTONICS CORP
NPTN
| $552K | ﹤0.01% |
46,202
+26,578
| +135% | +$301K |
|
3091
Cass Information Systems
CASS
$714M
| $550K | ﹤0.01% |
11,901
+7,308
| +159% | +$317K |
|
|
ECOM
3092
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $550K | ﹤0.01% |
23,352
+9,415
| +68% | +$208K |
|
|
PTR
3093
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $549K | ﹤0.01% |
15,176
-2,615
| -15% | -$90.5K |
|
|
CHS
3094
DELISTED
Chicos FAS, Inc.
CHS
| $547K | ﹤0.01% |
165,383
+32,836
| +25% | +$86.4K |
|
3095
Avnet
AVT
$7.29B
| $546K | ﹤0.01% |
13,119
-10,645
| -45% | -$412K |
|
3096
First Bancorp
FNLC
$396M
| $544K | ﹤0.01% |
18,633
+5,492
| +42% | +$147K |
|
3097
abrdn Physical Gold Shares ETF
SGOL
$6.91B
| $543K | ﹤0.01% |
33,130
| – | – |
|
3098
Vanguard Morningstar Value ETF
VTV
$188B
| $543K | ﹤0.01% |
4,138
+2,050
| +98% | +$257K |
|
|
CSTR
3099
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $543K | ﹤0.01% |
31,444
+1,029
| +3% | +$16.5K |
|
|
TRUE
3100
DELISTED
TrueCar
TRUE
| $540K | ﹤0.01% |
113,000
+64,589
| +133% | +$320K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.